le 22 octobre 2021

The Patient Protection and Affordable Care Act (PPACA) requires most Commercial health plans to cover a range of preventive services and products at no cost to patients. To remain compliant, each Commercial payer establishes and maintains a Preventive Drug List (PDL) that specifies a list of preventive products and services, as mandated by the law. 

For drug or medical device manufacturers developing products with potential preventive use, getting onto a payer’s PDL provides an opportunity to minimize access barriers from a coverage, reimbursement and patient cost sharing standpoint. It could, potentially, also allow for increased patient awareness, product utilization and maximized commercial success.


Download the article to learn more about PDLs.

Scroll to Page Bottom Form 
Powered by Translations.com GlobalLink OneLink Software